107 related articles for article (PubMed ID: 21296258)
1. Continuous epidural blockade for treatment of drug-induced priapism.
Bravenec BJ; Lenkovsky F; Iyer C; Vornik V; Sum-Ping J; Makary L; Evans KJ; Joshi GP
J Clin Anesth; 2011 Feb; 23(1):83-4. PubMed ID: 21296258
[No Abstract] [Full Text] [Related]
2. Intraurethral alprostadil for impotence.
Med Lett Drugs Ther; 1997 Mar; 39(997):32. PubMed ID: 9121395
[No Abstract] [Full Text] [Related]
3. [Alprostadil].
Taéron C
Rev Infirm; 2009 Dec; (156):47-9. PubMed ID: 20085033
[No Abstract] [Full Text] [Related]
4. [Prostaglandin in the treatment of impotence].
Tammela T
Duodecim; 1998; 114(4):371-5. PubMed ID: 11466950
[No Abstract] [Full Text] [Related]
5. [Priapism after intracavernous injection of PgE1 in two cases of impotence following total cysto-prostatectomy].
Llopis J; Romero JA; Gutiérrez R; Alvarez R; Talbot R; Vendrell JR; Barranco MA; Carretero P
J Urol (Paris); 1995; 101(2):104-6. PubMed ID: 8522852
[TBL] [Abstract][Full Text] [Related]
6. Priapism associated with concurrent use of phosphodiesterase inhibitor drugs and intracavernous injection therapy.
McMahon CG
Int J Impot Res; 2003 Oct; 15(5):383-4. PubMed ID: 14562142
[No Abstract] [Full Text] [Related]
7. Priapism after transurethral alprostadil.
Bettocchi C; Ashford L; Pryor JP; Ralph DJ
Br J Urol; 1998 Jun; 81(6):926. PubMed ID: 9666789
[No Abstract] [Full Text] [Related]
8. The incidence and management of priapism in Western Australia: a 16 year audit.
Earle CM; Stuckey BG; Ching HL; Wisniewski ZS
Int J Impot Res; 2003 Aug; 15(4):272-6. PubMed ID: 12934055
[TBL] [Abstract][Full Text] [Related]
9. Myocardial infarction associated with intra-cavernosal administration of alprostadil in a patient with spinal cord injury and paraplegia.
Vaidyanathan S; Krishnan KR
Spinal Cord; 1996 Dec; 34(12):754-5. PubMed ID: 8961437
[No Abstract] [Full Text] [Related]
10. Prostaglandin E1 in the therapy of erectile deficiency.
Beretta G; Zanollo A; Ascani L; Re B
Acta Eur Fertil; 1989; 20(5):305-8. PubMed ID: 2636808
[TBL] [Abstract][Full Text] [Related]
11. Intracavernous pharmacotherapy: comparison of Moxisylyte and prostaglandin E1.
Buvat J; Lemaire A; Herbaut-Buvat M
Int J Impot Res; 1996 Jun; 8(2):41-6. PubMed ID: 8858388
[TBL] [Abstract][Full Text] [Related]
12. [Current role of intracavernous therapy in the treatment of erectile dysfunction].
Asuar Aydillo S
Arch Esp Urol; 2002 Jun; 55(5):475-82. PubMed ID: 12174413
[No Abstract] [Full Text] [Related]
13. Intracorporeal phenylephrine in the treatment of priapism.
Muruve N; Hosking DH
J Urol; 1996 Jan; 155(1):141-3. PubMed ID: 7490814
[TBL] [Abstract][Full Text] [Related]
14. [Stasis priapism secondary to PGE1: transformation into high-flow priapism].
Negrín Díaz A; Díaz Romero F; Fernández Ramos J; Gutiérrez Hernández P; Arteaga Serrano F; Bañares Baudet F
Actas Urol Esp; 1996 Mar; 20(3):289-91. PubMed ID: 8712048
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of intracavernosal alprostadil in men with erectile dysfunction. The Alprostadil Study Group.
Linet OI; Ogrinc FG
N Engl J Med; 1996 Apr; 334(14):873-7. PubMed ID: 8596569
[TBL] [Abstract][Full Text] [Related]
16. Clinical conversations: intraurethral alprostadil (MUSE). Interview by Patricia Bates.
Lewis J; Helfrick B; Marzucco J
Urol Nurs; 1997 Dec; 17(4):159-61. PubMed ID: 9451246
[No Abstract] [Full Text] [Related]
17. Intracavernous injection of prostaglandin E1 in spinal cord injured patients with erectile dysfunction. A preliminary report.
Tang SF; Chu NK; Wong MK
Paraplegia; 1995 Dec; 33(12):731-3. PubMed ID: 8927414
[TBL] [Abstract][Full Text] [Related]
18. [Transurethral alprostadil (MUSE) in erectile dysfunction].
Comeri G; Gianneo E; Nespoli R
Arch Ital Urol Androl; 1999 Sep; 71(4):249-51. PubMed ID: 10592541
[TBL] [Abstract][Full Text] [Related]
19. Prostaglandin E1 in the medical management of erectile dysfunction in a genito-urinary medicine clinic.
Armstrong DK; Convery A; Dinsmore WW
Ulster Med J; 1994 Apr; 63(1):18-22. PubMed ID: 8658990
[TBL] [Abstract][Full Text] [Related]
20. Intracavernous injections for erectile dysfunction in patients with cardiovascular diseases and failure or contraindications for sildenafil citrate.
Israilov S; Niv E; Livne PM; Shmueli J; Engelstein D; Segenreich E; Baniel J
Int J Impot Res; 2002 Feb; 14(1):38-43. PubMed ID: 11896476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
